The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse

Conditions

Smoking

What is the purpose of this trial?

The purpose of this study is to examine how medications thought to attenuate the effects of alcohol (naltrexone) and smoking cessation medications (varenicline) affect the ability to resist smoking and also subsequent ad-lib smoking, following a low-dose alcohol priming drink, in non-treatment seeking alcohol-drinking daily smokers.



Participation Guidelines

Age:
21 Years - 55 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
January 2008
Last Updated:
October 7, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT00773422